Blow for Spectranetics as leg artery treatment refused
This article was originally published in Clinica
Spectranetics received a blow yesterday when a US FDA advisory panel recommended against approving its laser angioplasty treatment for critical limb ischaemia.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.